R-CVP regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Rituximab-Cyclophosphamide-Vincristine-Prednisone regimen
Overview
R-CVP regimen refers to a regimen consisting of rituximab, cyclophosphamide, vincristine (Oncovin), and prednisone used to treat both indolent and aggressive forms of diffuse large B-cell lymphoma.[1]
Regimen
RRituximab
CCyclophosphamide
VVincristine (Oncovin)
PPrednisone
Indications
References
- ↑ 1.0 1.1 Carbone J, Perez-Fernandez R, Muñoz A, Sabin P, Carreño L, Fernandez-Cruz E (2008). “Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren’s syndrome-associated B-cell non-Hodgkin’s lymphoma”. Clin Rev Allergy Immunol. 34 (1): 80–4. doi:10.1007/s12016-007-8025-2. PMID 18270861.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH